市场调查报告书
商品编码
1470990
腹膜透析市场:按类型、产品和最终用途划分 - 2024-2030 年全球预测Peritoneal Dialysis Market by Type (Automated Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis), Product (Dialysis Solution, Peritoneal Dialysis Catheters), End Use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年腹膜透析市场规模为50亿美元,预计2024年将达53.3亿美元,2030年将达80.3亿美元,复合年增长率为7.01%。
腹膜透析是一种医疗技术,用于肾臟功能不正常时排放体内多余的液体和废物。此手术使用腹膜(腹腔内衬的膜)作为过滤器。在腹膜透析中,一种特殊的液体会经由导管引入腹腔以吸收废物和多余的液体。然后将液体排放并处理,通常一天几次。糖尿病和高血压等疾病的增加是慢性肾臟病的主要原因,这大大增加了腹膜透析的需求。此外,由于其便利性和成本效益,人们越来越倾向于在家中进行透析治疗,从而推动了腹膜透析的采用。然而,腹膜炎的风险可能导致严重的併发症,这对腹膜透析提出了重大挑战。此外,旨在提高患者舒适度和治疗效果的透析解决方案和设备的创新为製造商提供了机会。利用远端医疗对腹膜透析患者进行远端监测可以改善患者的治疗效果并扩大市场范围。
主要市场统计 | |
---|---|
基准年[2023] | 50亿美元 |
预测年份 [2024] | 53.3亿美元 |
预测年份 [2030] | 80.3亿美元 |
复合年增长率(%) | 7.01% |
持续的门诊透析变得更加重要,因为它可以更灵活地控制透析过程。
自动腹膜透析主要使用称为週期计的机器在夜间患者睡觉时进行透析。这种类型的透析非常适合需要弹性安排日常安排或无法全天手动进行透析的患者。另一方面,连续门诊透析是不使用机器的手动透析。患者或看护者每天手动进行 4 至 5 次更改。想要保持一定程度的体力活动或无法获得 APD 所需的可靠电力的患者通常更喜欢这种方法。
最终用途:需要更密切医疗管理的患者通常更喜欢透析中心。
透析中心是专门提供透析治疗的设施,包括血液透析机和腹膜透析。透析中心是专门提供透析治疗的设施,包括血液透析机和血液透析机。选择 PD 的患者可以在这些机构接受医疗保健专业人员的直接监督和帮助。腹膜透析的居家照护环境意味着患者的住所配备了必要的腹膜透析设备和用品。居家腹膜透析无需频繁前往透析中心或医院,并允许根据患者的时间表进行透析治疗。提供腹膜透析的医院为处于透析初期、有多种健康状况且需要紧急护理的患者提供服务。医院拥有广泛的医疗服务和设施,可全面管理患者的健康,包括帕金森氏症併发症。
区域洞察
由于其先进的医疗保健系统、强大的患者支持计划以及对研究和专利的大量投资,美洲处于腹膜透析采用的前沿。医疗保险在其 ESRD(末期肾功能衰竭)福利下涵盖透析,并因其成本效益而鼓励 PD。持续创新的重点是改善透析解决方案和设备,以提高病患的安全性和便利性。在欧盟,透析的采用率正在稳步上升,儘管各国的情况有所不同。欧洲肾臟护理提供者协会 (ERCPA) 等倡议旨在标准化 PD 护理。研究投资重点是改善腹膜透析技术和减少腹膜炎。富裕的中东国家正在大力投资医疗保健,并增加对腹膜透析的兴趣。另一方面,非洲国家正面临医疗基础设施和医疗费用的挑战。这些区域倡议旨在透过伙伴关係和国际组织的资助来改善获得专业发展的机会。在 ESRD 患者数量较多的亚太地区,在政府医疗改革和透析中心投资的支持下,PD 的引入进展迅速。技术创新和腹膜透析用品的本地生产使治疗变得更加容易。此外,亚太地区也受惠于腹膜透析领域的强大研究倡议和技术进步。
FPNV定位矩阵
FPNV定位矩阵对于评估腹膜透析市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对腹膜透析市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估及资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行综合评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.腹膜透析市场规模及预测是多少?
2.腹膜透析市场预测期内需要考虑投资的产品、细分市场、应用及领域有哪些?
3. 腹膜透析市场的技术趋势和法规结构是什么?
4.腹膜透析市场主要厂商的市场占有率为何?
5.进入腹膜透析市场合适的型态和策略手段是什么?
[198 Pages Report] The Peritoneal Dialysis Market size was estimated at USD 5.00 billion in 2023 and expected to reach USD 5.33 billion in 2024, at a CAGR 7.01% to reach USD 8.03 billion by 2030.
Peritoneal dialysis is a medical technique used to draw excess fluid and waste products from the body when the kidneys are not functioning properly. This procedure employs the patient's peritoneum, a membrane lining the abdominal cavity, as a filter. During peritoneal dialysis, a special fluid is introduced into the abdominal cavity through a catheter, where it absorbs waste materials and excess fluids. The fluid is then drained and discarded, typically several times a day. An increase in conditions such as diabetes and hypertension, which are leading causes of CKD, significantly contributes to the demand for peritoneal dialysis. Additionally, there's a growing inclination towards getting dialysis treatment at home due to its convenience and cost-effectiveness, boosting the adoption of peritoneal dialysis. However, the risk of peritonitis, an infection of the peritoneum, which can lead to severe complications, poses significant challenges to peritoneal dialysis. Furthermore, innovations in dialysis solutions and devices aimed at improving patient comfort and treatment efficacy provide opportunities to the manufacturers. Leveraging telehealth for remote monitoring of peritoneal dialysis patients can improve patient outcomes and expand market reach.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.00 billion |
Estimated Year [2024] | USD 5.33 billion |
Forecast Year [2030] | USD 8.03 billion |
CAGR (%) | 7.01% |
Type: Increasing significance for continuous ambulatory peritoneal dialysis as it offers more flexibility and control over the dialysis process
Automated peritoneal dialysis primarily uses a machine called a cycler to perform exchanges at night while the patient sleeps. This type of dialysis is best suited for patients seeking flexibility in their daily schedule or those who are not capable of conducting manual exchanges throughout the day. Continuous ambulatory peritoneal dialysis, in contrast, is a manual dialysis method that does not require a machine. Exchanges are carried out four to five times a day, manually, by the patient or a caregiver. This modality is often preferred by patients who want to maintain a certain degree of physical activity or those who may not have access to reliable electricity needed for APD.
End Use: Patients requiring closer medical supervision often prefer dialysis centers
Dialysis Centers are facilities specifically designed to offer dialysis treatment, including both hemodialysis and peritoneal dialysis. For PD, these centers frequently serve as the initial point for education, training, and sometimes treatment. Patients opting for PD can receive direct supervision and assistance from healthcare professionals in these settings. Home care settings for peritoneal dialysis signify the patient's residence is equipped with the necessary PD equipment and supplies. Home PD allows patients to perform their dialysis treatment according to their schedule without the need to frequent a dialysis center or hospital. Hospitals offering peritoneal dialysis cater to patients who are either in the initiation phase of PD, have multiple health conditions, or require acute care management. Hospitals are equipped with a wide range of medical services and facilities for the comprehensive management of patient's health, including any complications from PD.
Regional Insights
The American region is at the forefront in terms of peritoneal dialysis adoption due to its advanced healthcare system, strong patient support programs, and significant investment in research and patents. Medicare, under the ESRD (End-Stage Renal Disease) benefit, provides coverage for dialysis, encouraging PD due to its cost-effectiveness. Ongoing innovations have focused on improving PD solutions and equipment aimed at enhancing patient safety and convenience. The EU has shown steady growth in PD adoption, with varying rates across countries. Initiatives such as the European Renal Care Providers Association (ERCPA) aim to standardize PD care. Investment in research focuses on improving PD technologies and reducing peritonitis. In wealthier Middle Eastern countries, there is significant investment in healthcare, with growing interest in peritoneal dialysis. In contrast, African countries face challenges related to healthcare infrastructure and affordability. Initiatives in these regions aim to improve access to PD through partnerships and funding from international organizations. With a large ESRD patient population, the APAC is witnessing rapid growth in PD adoption, supported by government reforms in healthcare and investment in dialysis centers. Innovations and localized production of peritoneal dialysis supplies have made the treatment more accessible. Moreover, the APAC benefits from strong research initiatives and technological advancements in peritoneal dialysis.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Peritoneal Dialysis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Peritoneal Dialysis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Peritoneal Dialysis Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Angiplast Pvt. Ltd., Asahi Kasei Corporation, AWAK Technologies, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cook Group Incorporated, DaVita Inc., Diaverum AB, Fresenius Medical Care AG & Co. KGaA, JDmeditech, JMS Co., Ltd., Medionics International Inc., Medtronic PLC, Mitra Industries, Nipro Corporation, Opterion Health AG, Renax Biomedical Technology Co., Ltd., Terumo Corporation, and Toray Industries, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Peritoneal Dialysis Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Peritoneal Dialysis Market?
3. What are the technology trends and regulatory frameworks in the Peritoneal Dialysis Market?
4. What is the market share of the leading vendors in the Peritoneal Dialysis Market?
5. Which modes and strategic moves are suitable for entering the Peritoneal Dialysis Market?